|

Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

RECRUITINGN/ASponsored by Peking University Third Hospital
Actively Recruiting
PhaseN/A
SponsorPeking University Third Hospital
Started2024-07-16
Est. completion2028-12-31
Eligibility
Age3 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06791226

Summary

To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in orbital neoplasms, and compared with 18F-FDG PET/CT.

Eligibility

Age: 3 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

1. patients with suspected or newly diagnosed orbital neoplasms (supporting evidence may include MRI, CT and pathology report);
2. patients who had scheduled both 18F-FDG and 18F-AlF-FAPI PET/CT scans;
3. patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria:

1. patients with pregnancy;
2. breastfeeding;
3. the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Conditions2

CancerOrbital Neoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.